Clinical Trial Update: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the SPYVLP01 human cytomegalovirus vaccine, with and without adjuvants, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• SPYVLP01

Snippet

Sponsor: SpyBiotech Limited | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED